ARTICLE | Financial News
PhaseRx proposes IPO
April 25, 2016 7:00 AM UTC
PhaseRx Inc., Seattle, Wash. Business: Endocrine/Metabolic Date announced: 2016-04-18 Type: IPO To be raised: Up to $25.3 million Shares: TBD Price: TBD Underwriter: Ladenburg Thalmann Note: PhaseRx i...